Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Tinostamustine

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GCAR And Purdue Pharma Initiate Tinostamustine In GBM AGILE Trial
    GCAR And Purdue Pharma Initiate Tinostamustine In GBM AGILE Trial

    11 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/gcar-and-purdue-pharma-lp-announce-initiation-of-tinostamustine-in-gbm-agile-trial-302736242.html

    PR NEWSWIRE
    11 Apr 2026
    Share Share
    Tinostamustine Demonstrates Early Efficacy In Phase 1
    Tinostamustine Demonstrates Early Efficacy In Phase 1

    19 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251119006848/en/Tinostamustine-Shows-Early-Signals-of-Activity-in-Phase-1-Glioblastoma-Trial

    BUSINESSWIRE
    19 Nov 2025
    Share Share
    FDA Grants Orphan Status To Tinostamustine For Malignant Glioma
    FDA Grants Orphan Status To Tinostamustine For Malignant Glioma

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110785101/en/FDA-Grants-Orphan-Drug-Designation-for-Tinostamustine-in-Malignant-Glioma

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Tinostamustine Included in GBM AGILE Trial for Glioblastoma
    Tinostamustine Included in GBM AGILE Trial for Glioblastoma

    17 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250917676784/en/Investigational-Drug-Tinostamustine-to-be-Included-in-GBM-AGILE-Clinical-Trial-for-Glioblastoma

    BUSINESSWIRE
    17 Sep 2025
    Share Share
    Purdue hires Ducharme as CSO to aid expansion beyond opioids
    Purdue hires Ducharme as CSO to aid expansion beyond opioids

    03 Jul 2019

    // Nick Paul FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/purdue-hires-ducharme-as-cso-to-aid-expansion-beyond-opioids?utm_source=internal&utm_medium=rss

    Nick Paul FIERCE BIOTECH
    03 Jul 2019
    Share Share
    Imbrium Announces USFDA Orphan Drug Designation for Tinostamustine
    Imbrium Announces USFDA Orphan Drug Designation for Tinostamustine

    28 Mar 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190328005218/en

    BUSINESSWIRE
    28 Mar 2019
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.